Post-Acute Phase of Cardiogenic Shock

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMackay Memorial Hospital

About this trial

Epidemiology studies showed that the burden of cardiogenic shock (CS) persistently high, with increasing annual medical expenses and steady prevalence. In-hospital and one-year mortality reduce annually. Hence, there are increasing number of patients who survive to hospital discharge but they will face further challenges in the subacute stage after hospital discharge. However, there are still insufficient studies focusing on this issue. Establishment of a healthcare neatwork to help hospital survivors of CS return society safely is critical.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Age < 18 years。

Patient or family refuse follow-up.

Patient died within hospital stay.

Trial population

Hospital survivors of cardiogenic shock

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

mortality

any death

Time frame
1 year
2

rehospitalization

any rehospitalization

Time frame
1 year

Secondary outcomes

1

mortality

any death

Time frame
90-day
2

rehospitalization

any rehospitalization

Time frame
90-day
3

mortality

any death

Time frame
180-day
4

rehospitalization

any rehospitalization

Time frame
180-day

Other outcomes

1

Quality

KCCQ

Time frame
1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.